Can nose-to-brain transport of anti-migraine drugs along the trigeminal nerve improve therapeutic effects while minimizing the risk of systemic adverse events?

Category Primary study
JournalCephalalgia
Year 2009
This article has no abstract
Epistemonikos ID: f1251eb0ab652561211d4c28bdcf787f40ea365c
First added on: Mar 01, 2025